Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-560-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20121023.45.2-560-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted in favour of ACAA, despite the official position of my political Group, because I do not find the arguments presented by colleagues convincing enough or relevant enough. We should not mix purely technical issues with complex political questions. This agreement is not an upgrade of the relations with Israel, it does not give a green light to further expansion of settlements, neither can it be seen as change in the political line of EU or EP towards the Middle East conflict. It is regrettable that this technical agreement has been elevated to such a political height that it finally blocked our own ability to negotiate and achieve the goals we initially have identified. If one says ‘no’ in advance and in any circumstances, then that in itself is a weak position. I believe that ACAA will give EU citizens a larger choice of, and easier access to, cheaper and higher quality medicines. That is a very good reason to support it. It is true that some European pharmaceutical giants would not be happy to face stronger competition on the European market, but finally it is people’s health which has to come first."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples